{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:12:07Z","timestamp":1772320327023,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s40618-016-0534-5","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T06:18:56Z","timestamp":1472537936000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fas\/FasL gene polymorphism in patients with Hashimoto\u2019s thyroiditis in Turkish population"],"prefix":"10.1007","volume":"40","author":[{"given":"M.","family":"Erdogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kulaksizoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ganidagli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Berdeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"issue":"4","key":"534_CR1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2012.02.003","volume":"12","author":"M Baki","year":"2012","unstructured":"Baki M, Akman FE, Vural P et al (2012) The combination of \u0131nterleukin-10 -1082 and tumor necrosis factor \u03b1 -308 or \u0131nterleukin-6 -174 genes polymorphisms suggests an association with susceptibility to\u00a0Hashimoto\u2019s thyroiditis. Int Immunopharmacol 12(4):543\u2013546","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"534_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.imbio.2014.03.009","volume":"219","author":"A Koc","year":"2014","unstructured":"Koc A, Batar B, Celik O, Onaran I, Tasan E, Sultuybek GK (2014) Polymorphism of the NFKB1 affects the serum inflammatory levels of\u00a0IL-6\u00a0in\u00a0Hashimoto\u00a0thyroiditis in a Turkish population. Immunobiology 219(7):531\u2013536","journal-title":"Immunobiology"},{"issue":"8","key":"534_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.gene.6364259","volume":"6","author":"RL Nolsoe","year":"2005","unstructured":"Nolsoe RL, Kelly JA, Pociot F et al (2005) Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 6(8):699\u2013706","journal-title":"Genes Immun"},{"issue":"6","key":"534_CR4","first-page":"1183","volume":"29","author":"S Kanemitsu","year":"2002","unstructured":"Kanemitsu S, Ihara K, Saifddin A et al (2002) A functional polymorphism in fas (CD95\/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 29(6):1183\u20131188","journal-title":"J Rheumatol"},{"issue":"1","key":"534_CR5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/art.10734","volume":"48","author":"AI Bolstad","year":"2003","unstructured":"Bolstad AI, Eiken HG, Rosenlund B, Alarcon-Riquelme ME, Jonsson R (2003) Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjogren\u2019s syndrome. Arthritis Rheum 48(1):174\u2013185","journal-title":"Arthritis Rheum"},{"issue":"10","key":"534_CR6","first-page":"2397","volume":"27","author":"AI Bolstad","year":"2000","unstructured":"Bolstad AI, Wargelius A, Nakken B, Haga HJ, Jonsson R (2000) Fas and Fas ligand gene polymorphisms in primary Sjogren\u2019s syndrome. J Rheumatol 27(10):2397\u20132405","journal-title":"J Rheumatol"},{"issue":"12","key":"534_CR7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/01.LAB.0000041700.09232.9C","volume":"82","author":"Z Dong","year":"2002","unstructured":"Dong Z, Takakuwa T, Takayama H et al (2002) Fas and Fas ligand gene mutations in Hashimoto\u2019s thyroiditis. Lab Investig 82(12):1611\u20131616","journal-title":"Lab Investig"},{"issue":"3","key":"534_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1099-0895(1998090)14:3<197::AID-DMR213>3.0.CO;2-G","volume":"14","author":"A Signore","year":"1998","unstructured":"Signore A, Annovazzi A, Gradini R, Liddi R, Ruberti G (1998) Fas\u00a0and\u00a0Fas\u00a0ligand-mediated apoptosis and its role in autoimmune diabetes. Diabetes Metab Rev 14(3):197\u2013206","journal-title":"Diabetes Metab Rev"},{"issue":"10","key":"534_CR9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/gtmb.2012.0173","volume":"16","author":"S Baydur Sahin","year":"2012","unstructured":"Baydur Sahin S, Cetinkalp S, Erdogan M, Yilmaz C, Berdeli A (2012) Fas, Fas ligand, and vitamin D receptor FokI gene polymorphism. Genet Test Mol Biomark 16(10):1179\u20131183","journal-title":"Genet Test Mol Biomark"},{"issue":"3","key":"534_CR10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12020-009-9258-z","volume":"36","author":"M Erdogan","year":"2009","unstructured":"Erdogan M, Erdem N, Cetinkalp S et al (2009) Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto\u2019s thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine 36(3):486\u2013490","journal-title":"Endocrine"},{"issue":"7","key":"534_CR11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10067-013-2466-1","volume":"33","author":"H Emmungil","year":"2014","unstructured":"Emmungil H, Erdogan M, Kalfa M et al (2014) Autoimmune thyroid disease in ankylosing spondylitis. Clin Rheumatol 33(7):955\u2013961","journal-title":"Clin Rheumatol"},{"key":"534_CR12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF03346319","volume":"30","author":"M Erdogan","year":"2007","unstructured":"Erdogan M, Karadeniz M, Berdeli A et al (2007) Fas\/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population. J Endocrinol Investig 30:411\u2013416","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"534_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1530\/eje.0.1490393","volume":"149","author":"BJ Stuck","year":"2003","unstructured":"Stuck BJ, Pani MA, Besrour F et al (2003) No association of two\u00a0Fas\u00a0gene polymorphisms with Hashimoto\u2019s thyroiditis and Graves\u2019 disease. Eur J Endocrinol 149(5):393\u2013396","journal-title":"Eur J Endocrinol"},{"issue":"2013","key":"534_CR14","doi-asserted-by":"crossref","first-page":"176741","DOI":"10.1155\/2013\/176741","volume":"14","author":"B Moudi","year":"2013","unstructured":"Moudi B, Salimi S, Farajian Mashhadi F, Sandoughi M, Zakeri Z (2013) Association of\u00a0FAS\u00a0and\u00a0FAS\u00a0ligand\u00a0genes\u00a0polymorphism\u00a0and risk of systemic lupus erythematosus. Sci World J 14(2013):176741","journal-title":"Sci World J"},{"issue":"1","key":"534_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11033-012-2075-0","volume":"40","author":"N Xiang","year":"2013","unstructured":"Xiang N, Li XM, Wang GS, Tao JH, Li XP (2013) Association of\u00a0Fas\u00a0gene\u00a0polymorphisms\u00a0with systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 40(1):407\u2013415","journal-title":"Mol Biol Rep"},{"issue":"2","key":"534_CR16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0198-8859(02)00775-9","volume":"64","author":"BJ Stuck","year":"2003","unstructured":"Stuck BJ, Pani MA, Besrour F et al (2003) Fas\u00a0ligand gene polymorphisms are not associated with Hashimoto\u2019s thyroiditis and Graves\u2019 disease. Hum Immunol 64(2):285\u2013289","journal-title":"Hum Immunol"},{"issue":"3","key":"534_CR17","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.4238\/2014.July.2.12","volume":"13","author":"BA Trevi\u00f1o-Talavera","year":"2014","unstructured":"Trevi\u00f1o-Talavera BA, Palafox-S\u00e1nchez CA, Mu\u00f1oz-Valle JF et al (2014) FAS\u00a0-670A > G promoter\u00a0polymorphism\u00a0is associated with soluble\u00a0Fas\u00a0levels in primary Sj\u00f6gren\u2019s syndrome. Genet Mol Res 13(3):4831\u20134838","journal-title":"Genet Mol Res"},{"issue":"6","key":"534_CR18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.dld.2014.02.003","volume":"46","author":"B Qin","year":"2014","unstructured":"Qin B, Li J, Liang Y, Yang Z, Zhong R (2014) The association between Cytotoxic T lymphocyte associate dantigen-4, Fas, TNF \u03b1 gene polymorphisms and autoimmune hepatitis: a meta-analysis. Dig Liver Dis 46(6):541\u2013548","journal-title":"Dig Liver Dis"},{"issue":"10","key":"534_CR19","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00296-013-2793-1","volume":"33","author":"S Y\u0131ld\u0131r","year":"2013","unstructured":"Y\u0131ld\u0131r S, Sezgin M, Barlas I\u00d6 et al (2013) Relation of the\u00a0Fas\u00a0and FasL\u00a0gene\u00a0polymorphisms\u00a0with susceptibility to and severity of rheumatoid arthritis. Rheumatol Int 33(10):2637\u20132645","journal-title":"Rheumatol Int"},{"issue":"5","key":"534_CR20","first-page":"303","volume":"36","author":"A Guerra","year":"2013","unstructured":"Guerra A, Sapio MR, Carrano M et al (2013) Prevalence\u00a0of\u00a0Dio2(T92A) polymorphism and its association with thyroid autoimmunity. J Endocrinol Investig 36(5):303\u2013306","journal-title":"J Endocrinol Investig"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0534-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0534-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0534-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:20:14Z","timestamp":1749568814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0534-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0534-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}